Literature DB >> 25504961

Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.

Sedat Yilmaz1, Muhammet Cinar2, Ismail Simsek2, Hakan Erdem2, Salih Pay2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25504961     DOI： 10.1093/rheumatology/keu474

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  14 in total

Review 1.  A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

Authors:  Andrea Rubbert-Roth; Daniel E Furst; Jan Michael Nebesky; Angela Jin; Erhan Berber
Journal:  Rheumatol Ther       Date:  2018-03-03

Review 2.  Recurrent fever and arthralgia as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Chinese girl: a case report and review of the literature.

Authors:  Yanxia Chen; Xingqi Huang; Sujie Zheng; Zhongliang Zhu; Wei Yang; Jinlin Liu
Journal:  Clin Rheumatol       Date:  2018-02-15       Impact factor: 2.980

Review 3.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

Review 4.  Familial Mediterranean fever: current perspectives.

Authors:  Hafize Emine Sönmez; Ezgi Deniz Batu; Seza Özen
Journal:  J Inflamm Res       Date:  2016-03-17

5.  Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever.

Authors:  Tomohiro Koga; Kiyoshi Migita; Shuntaro Sato; Masataka Umeda; Fumiaki Nonaka; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Yukitaka Ueki; Junya Masumoto; Kazunaga Agematsu; Akihiro Yachie; Koh-Ichiro Yoshiura; Katsumi Eguchi; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 6.  Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.

Authors:  Serdal Ugurlu; Aysa Hacioglu; Yasaman Adibnia; Vedat Hamuryudan; Huri Ozdogan
Journal:  Orphanet J Rare Dis       Date:  2017-05-30       Impact factor: 4.123

7.  Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever.

Authors:  Mustafa Çakar; Muharrem Akhan; Tolga Doğan; Gürhan Taşkın; Kadir Öztürk; Muhammet Çınar; Erol Arslan; Sedat Yılmaz
Journal:  Anatol J Cardiol       Date:  2016-07-21       Impact factor: 1.596

Review 8.  Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).

Authors:  Georges El Hasbani; Ali Jawad; Imad Uthman
Journal:  Orphanet J Rare Dis       Date:  2019-10-15       Impact factor: 4.123

Review 9.  Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

Authors:  Alessandra Soriano; Marco Soriano; Gerard Espinosa; Raffaele Manna; Giacomo Emmi; Luca Cantarini; José Hernández-Rodríguez
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

10.  Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF.

Authors:  Sedat Yılmaz; Emre Tekgöz; Muhammet Çınar
Journal:  Eur J Rheumatol       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.